First, due to the enhanced permeability and retention (EPR) effect, PDL1-NP-FEXO will enrich in tumor tissue, where PD-L1 aptamer and FEXO may produce better antitumor efficacy [25]. This evidence concerns the gene CD274 and neoplasm.